Table 1.
Clinical information of the 206 NSCLC patients
| SampleID | Gender | Age | Clinical diagnosis |
|---|---|---|---|
| P1 | Female | 63 | Non-small cell lung cancer |
| P2 | Male | 65 | Adenocarcinoma |
| P3 | Male | 79 | Adenocarcinoma |
| P4 | Male | 54 | Adenocarcinoma |
| P5 | Female | 68 | Adenocarcinoma |
| P6 | Male | 71 | Squamous |
| P7 | Female | 63 | Squamous |
| P8 | Male | 72 | Squamous |
| P9 | Male | 63 | Squamous |
| P10 | Male | 54 | Squamous |
| P11 | Female | 74 | Non-small-cell lung cancer |
| P12 | Male | 59 | Non-small-cell lung cancer |
| P13 | Male | 69 | Non-small-cell lung cancer |
| P14 | Male | 44 | Non-small-cell lung cancer |
| P15 | Male | 68 | Adenocarcinoma |
| P16 | Female | 49 | Non-small-cell lung cancer |
| P17 | Male | 57 | Adenocarcinoma |
| P18 | Female | 61 | Non-small-cell lung cancer |
| P19 | Male | 56 | Squamous |
| P20 | Male | 65 | Adenocarcinoma |
| P21 | Male | 63 | Squamous |
| P22 | Female | 64 | Non-small-cell lung cancer |
| P23 | Female | 57 | Non-small-cell lung cancer |
| P24 | Female | 45 | Adenocarcinoma |
| P25 | Female | 51 | Adenocarcinoma |
| P26 | Female | 50 | Adenocarcinoma |
| P27 | Male | 82 | Non-small-cell lung cancer |
| P28 | Male | 56 | Non-small-cell lung cancer |
| P29 | Female | 64 | Adenocarcinoma |
| P30 | Male | 71 | Non-small-cell lung cancer |
| P31 | Male | 46 | Adenocarcinoma |
| P32 | Male | 52 | Squamous |
| P33 | Female | 48 | Non-small-cell lung cancer |
| P34 | Male | 61 | Non-small-cell lung cancer |
| P35 | Male | 35 | Squamous |
| P36 | Male | 69 | Small cell lung cancer |
| P37 | Female | 69 | Non-small-cell lung cancer |
| P38 | Male | 64 | Non-small-cell lung cancer |
| P39 | Male | 65 | Non-small-cell lung cancer |
| P40 | Female | 75 | Non-small-cell lung cancer |
| P41 | Female | 58 | Adenocarcinoma |
| P42 | Female | 38 | Adenocarcinoma |
| P43 | Female | 63 | Non-small-cell lung cancer |
| P44 | Male | 62 | Non-small-cell lung cancer |
| P45 | Male | 79 | Non-small-cell lung cancer |
| P46 | Male | 51 | Non-small-cell lung cancer |
| P47 | Female | 60 | Adenocarcinoma |
| P48 | Male | 62 | Non-small-cell lung cancer |
| P49 | Male | 68 | Non-small-cell lung cancer |
| P50 | Female | 69 | Non-small-cell lung cancer |
| P51 | Female | 53 | Non-small-cell lung cancer |
| P52 | Female | 57 | Adenocarcinoma |
| P53 | Female | 61 | Adenocarcinoma |
| P54 | Male | 58 | Non-small-cell lung cancer |
| P55 | Male | 54 | Neuroendocrine |
| P56 | Female | 77 | Non-small-cell lung cancer |
| P57 | Female | 35 | Non-small-cell lung cancer |
| P58 | Female | 70 | Adenocarcinoma |
| P59 | Male | 79 | Non-small-cell lung cancer |
| P60 | Male | 66 | Non-small-cell lung cancer |
| P61 | Male | 68 | Non-small-cell lung cancer |
| P62 | Male | 68 | Non-small-cell lung cancer |
| P63 | Male | 61 | Non-small-cell lung cancer |
| P64 | Male | 80 | Non-small-cell lung cancer |
| P65 | Male | 70 | Non-small-cell lung cancer |
| P66 | Female | 39 | Adenocarcinoma |
| P67 | Female | 50 | Adenocarcinoma |
| P68 | Male | 67 | Non-small-cell lung cancer |
| P69 | Male | 49 | Non-small-cell lung cancer |
| P70 | Male | 72 | Adenocarcinoma |
| P71 | Male | 54 | Non-small-cell lung cancer |
| P72 | Male | 52 | Adenocarcinoma |
| P73 | Female | 68 | Non-small-cell lung cancer |
| P74 | Female | 73 | Non-small-cell lung cancer |
| P75 | Male | 69 | Adenocarcinoma |
| P76 | Female | 71 | Adenocarcinoma |
| P77 | Female | 66 | Non-small-cell lung cancer |
| P78 | Male | 69 | Adenocarcinoma |
| P79 | Male | 62 | Squamous |
| P80 | Male | 54 | Non-small-cell lung cancer |
| P81 | Female | 47 | Non-small-cell lung cancer |
| P82 | Male | 76 | Non-small-cell lung cancer |
| P83 | Male | 86 | Non-small-cell lung cancer |
| P84 | Male | 73 | Non-small-cell lung cancer |
| P85 | Male | 72 | Non-small-cell lung cancer |
| P86 | Male | 43 | Adenocarcinoma |
| P87 | Female | 67 | Adenocarcinoma |
| P88 | Male | 55 | Non-small-cell lung cancer |
| P89 | Male | 77 | Small cell lung cancer |
| P90 | Male | 57 | Non-small-cell lung cancer |
| P91 | Female | 54 | Adenocarcinoma |
| P92 | Male | 65 | Neuroendocrine |
| P93 | Female | 72 | Adenocarcinoma |
| P94 | Male | 62 | Squamous |
| P95 | Female | 45 | Non-small-cell lung cancer |
| P96 | Female | 45 | Non-small-cell lung cancer |
| P97 | Female | 51 | Adenocarcinoma |
| P98 | Female | 65 | Non-small-cell lung cancer |
| P99 | Male | 61 | Adenocarcinoma |
| P100 | Male | 79 | Squamous |
| P101 | Female | 64 | Adenocarcinoma |
| P102 | Male | 75 | Non-small-cell lung cancer |
| P103 | Male | 67 | Adenocarcinoma |
| P104 | Male | 72 | Non-small-cell lung cancer |
| P105 | Male | 79 | Adenocarcinoma |
| P106 | Female | 51 | Non-small-cell lung cancer |
| P107 | Female | 78 | Non-small-cell lung cancer |
| P108 | Male | 58 | Non-small-cell lung cancer |
| P109 | Female | 69 | Adenocarcinoma |
| P110 | Male | 82 | Non-small-cell lung cancer |
| P111 | Male | 76 | Non-small-cell lung cancer |
| P112 | Male | 61 | Adenocarcinoma |
| P113 | Female | 64 | Adenocarcinoma |
| P114 | Female | 69 | Non-small-cell lung cancer |
| P115 | Male | 85 | Adenocarcinoma |
| P116 | Male | 56 | Non-small-cell lung cancer |
| P117 | Female | 62 | Non-small-cell lung cancer |
| P118 | Male | 62 | Squamous |
| P119 | Male | 56 | Squamous |
| P120 | Male | 68 | Squamous |
| P121 | Male | 63 | Adenocarcinoma |
| P122 | Male | 58 | Non-small-cell lung cancer |
| P123 | Male | 64 | Adenocarcinoma |
| P124 | Male | 68 | Non-small-cell lung cancer |
| P125 | Male | 59 | Adenocarcinoma |
| P126 | Male | 67 | Non-small-cell lung cancer |
| P127 | Female | 78 | Non-small-cell lung cancer |
| P128 | Female | 66 | Non-small-cell lung cancer |
| P129 | Female | 67 | Non-small-cell lung cancer |
| P130 | Female | 57 | Non-small-cell lung cancer |
| P131 | Female | 74 | Non-small-cell lung cancer |
| P132 | Male | 55 | Non-small-cell lung cancer |
| P133 | Male | 62 | Squamous |
| P134 | Male | 66 | Squamous |
| P135 | Female | 56 | Non-small-cell lung cancer |
| P136 | Male | 60 | Non-small-cell lung cancer |
| P137 | Male | 81 | Non-small-cell lung cancer |
| P138 | Male | 63 | Non-small-cell lung cancer |
| P139 | Female | 49 | Adenocarcinoma |
| P140 | Male | 56 | Non-small-cell lung cancer |
| P141 | Male | 74 | Non-small-cell lung cancer |
| P142 | Female | 49 | Non-small-cell lung cancer |
| P143 | Male | 65 | Non-small-cell lung cancer |
| P144 | Female | 52 | Adenocarcinoma |
| P145 | Male | 40 | Non-small-cell lung cancer |
| P146 | Male | 66 | Adenocarcinoma |
| P147 | Female | 65 | Small cell lung cancer |
| P148 | Female | 68 | Large cell lung cancer |
| P149 | Male | 41 | Adenocarcinoma |
| P150 | Male | 54 | Adenocarcinoma |
| P151 | Female | 53 | Non-small-cell lung cancer |
| P152 | Male | 76 | Non-small-cell lung cancer |
| P153 | Female | 49 | Non-small-cell lung cancer |
| P154 | Female | 71 | Adenocarcinoma |
| P155 | Male | 69 | Non-small-cell lung cancer |
| P156 | Male | 60 | Adenocarcinoma |
| P157 | Male | 52 | Non-small-cell lung cancer |
| P158 | Female | 68 | Non-small-cell lung cancer |
| P159 | Male | 62 | Adenocarcinoma |
| P160 | Male | 75 | Non-small-cell lung cancer |
| P161 | Male | 65 | Non-small-cell lung cancer |
| P162 | Male | 65 | Non-small-cell lung cancer |
| P163 | Male | 55 | Non-small-cell lung cancer |
| P164 | Male | 68 | Non-small-cell lung cancer |
| P165 | Male | 57 | Adenocarcinoma |
| P166 | Female | 48 | Neuroendocrine |
| P167 | Male | 73 | Adenocarcinoma |
| P168 | Male | 62 | Adenocarcinoma |
| P169 | Female | 70 | Adenocarcinoma |
| P170 | Female | 61 | Non-small-cell lung cancer |
| P171 | Male | 65 | Adenocarcinoma |
| P172 | Male | 75 | Non-small-cell lung cancer |
| P173 | Male | 53 | Non-small-cell lung cancer |
| P174 | Female | 53 | Non-small-cell lung cancer |
| P175 | Male | 75 | Adenocarcinoma |
| P176 | Male | 40 | Non-small-cell lung cancer |
| P177 | Male | 65 | Non-small-cell lung cancer |
| P178 | Female | 67 | Non-small-cell lung cancer |
| P179 | Male | 70 | Non-small-cell lung cancer |
| P180 | Male | 55 | Non-small-cell lung cancer |
| P181 | Female | 68 | Small cell lung cancer |
| P182 | Male | 56 | Adenocarcinoma |
| P183 | Male | 66 | Non-small-cell lung cancer |
| P184 | Female | 70 | Non-small-cell lung cancer |
| P185 | Male | 62 | Squamous |
| P186 | Female | 55 | Adenocarcinoma |
| P187 | Female | 71 | Adenocarcinoma |
| P188 | Female | 63 | Adenocarcinoma |
| P189 | Female | 69 | Non-small-cell lung cancer |
| P190 | Female | 51 | Adenocarcinoma |
| P191 | Female | 46 | Adenocarcinoma |
| P192 | Female | 74 | Non-small-cell lung cancer |
| P193 | Female | 61 | Non-small-cell lung cancer |
| P194 | Male | 47 | Non-small-cell lung cancer |
| P195 | Male | 68 | Squamous |
| P196 | Male | 49 | Non-small-cell lung cancer |
| P197 | Female | 83 | Non-small-cell lung cancer |
| P198 | Female | 66 | Adenocarcinoma |
| P199 | Male | 56 | Squamous |
| P200 | Male | 54 | Non-small-cell lung cancer |
| P201 | Male | 51 | Non-small-cell lung cancer |
| P202 | Female | 70 | Adenocarcinoma |
| P203 | Female | 62 | Non-small-cell lung cancer |
| P204 | Male | 66 | Adenocarcinoma |
| P205 | Male | 56 | Non-small-cell lung cancer |
| P206 | Male | 63 | Adenocarcinoma |